Shalby quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	331	296	+11.7%
EBITDA	41.6	41.5	+0.1%
EBITDA margin	12.6%	14.0%	−1.4 pts
Profit before tax	19.7	22.7	−13.1%
Net profit	10.5	7.7	+36.7%
EPS	₹0.98	₹0.71	+38.0%

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Q2 FY24Sep 2023	Earlier quartersAlpha Plus

Expenses
	331	287	272	285	296	265	276	268	279	244	216	238	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	7.4	8.1	7.2	4.5	7.0	5.3	5.4	7.2	9.7	5.0	4.5	5.4
	339	296	279	290	303	270	281	275	289	249	221	243
	8.2	14.9	17.7	16.7	15.5	22.3	69.4	66.3	13.3	7.8	7.3	48.9
	42.0	41.2	32.1	31.2	29.3	27.6	28.7	23.3	24.3	17.6	19.1	19.5
	13.4	−12.7	−15.5	−12.6	−6.6	−13.5	−31.7	−23.9	−12.9	−8.7	−11.4	−16.2
	47.9	49.6	47.0	45.2	46.5	44.8	47.8	47.1	44.9	39.9	37.8	38.6
	10.6	9.3	10.6	9.6	9.4	10.7	10.7	9.3	8.1	6.5	3.6	3.2
	18.7	18.5	17.6	17.4	16.5	16.2	16.3	16.8	16.4	15.6	12.4	12.3
	178	165	161	163	170	163	128	122	164	149	121	94.5
	319	286	270	271	281	271	269	261	258	227	190	201
	41.6	29.4	30.3	41.6	41.5	20.8	33.9	32.6	45.2	38.9	42.3	52.7
	22.8	10.9	12.6	24.2	25.0	4.6	17.6	15.8	28.8	23.3	29.9	40.4
Profit
	19.7	9.6	9.2	19.1	22.7	−0.7	12.4	13.7	30.4	21.8	30.8	42.6
	19.7	9.6	9.2	19.1	22.7	−0.7	12.4	13.7	30.4	21.8	30.8	42.6
	11.9	4.2	7.2	14.3	18.3	10.3	13.1	13.3	18.6	11.8	14.8	17.8
	−2.7	−13.1	0.8	−2.5	−3.4	1.2	2.2	−2.0	−2.9	−6.0	−3.0	−2.7
	9.2	−8.8	8.0	11.8	15.0	11.4	15.3	11.3	15.7	5.7	11.7	15.1
	10.5	18.5	1.3	7.3	7.7	−12.2	−3.0	2.4	14.7	16.0	19.1	27.6
	10.5	18.5	1.3	7.3	7.7	−12.2	−3.0	2.4	14.7	16.0	19.1	27.6
	0.5	−14.4	−2.8	−7.0	−0.5	0.4	−2.8	−0.3	0.0	0.7	0.0	−0.4
	11.0	4.0	−1.5	0.2	7.2	−11.8	−5.7	2.1	14.8	16.8	19.1	27.2
	10.8	18.3	1.8	8.4	8.9	−11.0	−3.0	3.4	—	—	19.1	27.6
	−0.3	0.1	−0.5	−1.1	−1.2	−1.2	0.0	−1.0	—	—	−0.0	−0.0
Per share
	₹0.98	₹1.72	₹0.12	₹0.68	₹0.71	−₹1.13	−₹0.28	₹0.22	₹1.37	₹1.49	₹1.78	₹2.57
	₹0.98	₹1.72	₹0.12	₹0.68	₹0.71	−₹1.13	−₹0.28	₹0.22	₹1.37	₹1.49	₹1.78	₹2.57
Other comprehensive income — detail
	0.5	−14.4	−2.8	−7.0	−0.5	0.4	—	—	—	—	—	—
	−0.1	0.4	−0.1	−7.1	0.1	−0.4	0.1	0.1	0.1	0.7	0.1	−0.4
	−0.0	0.0	−0.0	−0.1	0.0	−0.2	—	—	—	—	—	—
	—	—	—	—	—	—	0.0	0.0	0.0	0.0	0.0	0.0
	0.5	−14.8	−2.8	—	−0.5	—	−2.8	−0.3	—	—	—	—
	0.0	0.0	0.0	—	0.0	−0.5	—	—	—	—	—	—
	—	—	—	—	—	—	0.0	0.0	0.0	0.0	0.1	0.0
	11.3	3.9	—	1.3	9.4	−10.7	—	3.1	—	16.6	19.1	27.2
	−0.3	0.2	—	−1.1	−1.2	−1.1	—	−1.0	—	−0.6	−0.0	−0.0
Per share — as-filed variants
	₹0.98	₹1.72	₹0.12	₹0.68	₹0.71	₹0.00	−₹0.28	₹0.22	₹1.37	₹1.49	₹1.78	₹2.57
	₹0.98	₹1.72	₹0.12	₹0.68	₹0.71	₹0.00	−₹0.28	₹0.22	₹1.37	₹1.49	₹1.78	₹2.57
	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	−₹1.13	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00
	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	−₹1.13	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00	₹0.00
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	268	244	238	250	258	228	209	202	254	228	201	186
	80.8%	84.9%	87.4%	87.6%	87.1%	86.2%	75.9%	75.4%	91.1%	93.2%	93.0%	78.1%
Adjusted (ex-exceptional items) — derived
	19.7	9.6	9.2	19.1	22.7	−0.7	12.4	13.7	30.4	21.8	30.8	42.6
	10.5	18.5	1.3	7.3	7.7	−12.2	−3.0	2.4	14.7	16.0	19.1	27.6
	₹0.98	₹1.72	₹0.12	₹0.68	₹0.71	−₹1.13	−₹0.28	₹0.22	₹1.37	₹1.49	₹1.78	₹2.57

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SHALBY₹121.96

Shalby Limited

· Pharma & Health

Annual Quarterly₹ CrorePeersGKSL GPTHEALTH INDRAMEDCO ARTEMISMED LOTUSEYE DRAGARWQ KMCSHIL KOVAIMcap ₹1,311 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	238.0	216.0	244.2	278.9	267.5	275.6	264.9	296.4	285.4	272.1	287.4	331.2
Other Income	5.4	4.5	5.0	9.7	7.2	5.4	5.3	7.0	4.5	7.2	8.1	7.4
Total Income	243.4	220.6	249.2	288.6	274.7	281.1	270.2	303.4	289.9	279.4	295.5	338.6
Expenses
+ Cost of Materials Consumed	48.9	7.3	7.8	13.3	66.3	69.4	22.3	15.5	16.7	17.7	14.9	8.2
+ Purchases of Stock-in-Trade	19.5	19.1	17.6	24.3	23.3	28.7	27.6	29.3	31.2	32.1	41.2	42.0
+ Changes in Inventories	-16.2	-11.4	-8.7	-12.9	-23.9	-31.7	-13.5	-6.6	-12.6	-15.5	-12.7	13.4
+ Employee Benefit Expense	38.6	37.8	39.9	44.9	47.1	47.8	44.8	46.5	45.2	47.0	49.6	47.9
+ Finance Costs	3.2	3.6	6.5	8.1	9.3	10.7	10.7	9.4	9.6	10.6	9.3	10.6
+ Depreciation & Amortisation	12.3	12.4	15.6	16.4	16.8	16.3	16.2	16.5	17.4	17.6	18.5	18.7
+ Other Expenses	94.5	120.9	148.7	164.1	122.0	127.6	162.8	170.2	163.3	160.5	165.1	178.1
Total Expenses	200.7	189.8	227.4	258.2	261.0	268.7	271.0	280.8	270.8	270.1	285.9	318.9
EBITDA	52.7	42.3	38.9	45.2	32.6	33.9	20.8	41.5	41.6	30.3	29.4	41.6
EBIT	40.4	29.9	23.3	28.8	15.8	17.6	4.6	25.0	24.2	12.6	10.9	22.8
Profit
PBT before Exceptional Items	42.6	30.8	21.8	30.4	13.7	12.4	-0.7	22.7	19.1	9.2	9.6	19.7
Pretax Income	42.6	30.8	21.8	30.4	13.7	12.4	-0.7	22.7	19.1	9.2	9.6	19.7
+ Current Tax	17.8	14.8	11.8	18.6	13.3	13.1	10.3	18.3	14.3	7.2	4.2	11.9
+ Deferred Tax	-2.7	-3.0	-6.0	-2.9	-2.0	2.2	1.2	-3.4	-2.5	0.8	-13.1	-2.7
Tax Expense	15.1	11.7	5.7	15.7	11.3	15.3	11.4	15.0	11.8	8.0	-8.8	9.2
Net Income	27.6	19.1	16.0	14.7	2.4	-3.0	-12.2	7.7	7.3	1.3	18.5	10.5
+ Net Income — Continuing Ops	27.6	19.1	16.0	14.7	2.4	-3.0	-12.2	7.7	7.3	1.3	18.5	10.5
+ Other Comprehensive Income	-0.4	0.0	0.7	0.0	-0.3	-2.8	0.4	-0.5	-7.0	-2.8	-14.4	0.5
Total Comprehensive Income	27.2	19.1	16.8	14.8	2.1	-5.7	-11.8	7.2	0.2	-1.5	4.0	11.0
Net Income to Common	27.6	19.1	—	—	3.4	-3.0	-11.0	8.9	8.4	1.8	18.3	10.8
Minority Interest	-0.0	-0.0	—	—	-1.0	0.0	-1.2	-1.2	-1.1	-0.5	0.1	-0.3
Per Share
Basic EPS	2.57	1.78	1.49	1.37	0.22	-0.28	-1.13	0.71	0.68	0.12	1.72	0.98
Diluted EPS	2.57	1.78	1.49	1.37	0.22	-0.28	-1.13	0.71	0.68	0.12	1.72	0.98
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	0.4	-0.5	-7.0	-2.8	-14.4	0.5
+ Items NOT to be Reclassified to P&L	-0.4	0.1	0.7	0.1	0.1	0.1	-0.4	0.1	-7.1	-0.1	0.4	-0.1
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	-0.2	0.0	-0.1	-0.0	0.0	-0.0
+ Tax on Items NOT to be Reclassified — alt tag	0.0	0.0	0.0	0.0	0.0	0.0	—	—	—	—	—	—
+ Items to be Reclassified to P&L	—	—	—	—	-0.3	-2.8	—	-0.5	—	-2.8	-14.8	0.5
+ Tax on Items to be Reclassified	—	—	—	—	—	—	-0.5	0.0	—	0.0	0.0	0.0
+ Tax on Items to be Reclassified — alt tag	0.0	0.1	0.0	0.0	0.0	0.0	—	—	—	—	—	—
Comprehensive Income — Owners of Parent	27.2	19.1	16.6	—	3.1	—	-10.7	9.4	1.3	—	3.9	11.3
Comprehensive Income — Non-controlling Interests	-0.0	-0.0	-0.6	—	-1.0	—	-1.1	-1.2	-1.1	—	0.2	-0.3
Per Share — as-filed variants
Basic EPS — Continuing Operations	2.57	1.78	1.49	1.37	0.22	-0.28	0.00	0.71	0.68	0.12	1.72	0.98
Diluted EPS — Continuing Operations	2.57	1.78	1.49	1.37	0.22	-0.28	0.00	0.71	0.68	0.12	1.72	0.98
Basic EPS — Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	-1.13	0.00	0.00	0.00	0.00	0.00
Diluted EPS — Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	-1.13	0.00	0.00	0.00	0.00	0.00
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	185.8	201.0	227.5	254.2	201.8	209.3	228.4	258.2	250.2	237.8	244.0	267.5
Gross Margin %	78.07	93.05	93.16	91.14	75.43	75.93	86.24	87.11	87.64	87.38	84.87	80.77
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	42.6	30.8	21.8	30.4	13.7	12.4	-0.7	22.7	19.1	9.2	9.6	19.7
Net Income Adj (tax-effected)	27.6	19.1	16.0	14.7	2.4	-3.0	-12.2	7.7	7.3	1.3	18.5	10.5
EPS Adj	2.57	1.78	1.49	1.37	0.22	-0.28	-1.13	0.71	0.68	0.12	1.72	0.98
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	107.3	107.4	107.4	107.5	107.5	107.5	107.5	107.5	107.5	107.5	107.5	107.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Shalby Q2 FY27 results date

Shalby (NSE: SHALBY) will announce its Q2 FY27 results (July–September 2026) on Tuesday, 3 November 2026, according to the board-meeting notice it filed on 22 October 2026. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit was ₹10.8 crore, up 21.6% from ₹8.9 crore in Q1 FY26 and down 40.8% from ₹18.3 crore in Q4 FY26. Revenue from operations was ₹331 crore, up 11.7% year on year and up 15.2% from the previous quarter.

Board-meeting notice filed: 22 October 2026
Q2 FY26 results (a year earlier): 13 November 2025
Q1 FY27 results (the latest): 12 August 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results date: 3 November 2026Tuesday · notice filed 22 Oct
Q1 FY27 net profit: ₹10.8 Cr+21.6% vs Q1 FY26−40.8% vs Q4 FY26
Q1 FY27 revenue: ₹331 Cr+11.7% vs Q1 FY26+15.2% vs Q4 FY26
Q1 FY27 operating margin: 6.9%−1.5 pts vs Q1 FY26+3.1 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier): ₹8.4 CrRevenue ₹285 Cr
Q1 FY27 EPS (basic): ₹0.98

Questions

When will Shalby announce its Q2 FY27 results?

On 3 November 2026, the date of the board meeting called to approve them (notice filed with the exchanges on 22 October 2026). Last year it reported Q2 FY26 on 13 November 2025.

What were Shalby's Q1 FY27 results?

Consolidated net profit was ₹10.8 crore, up 21.6% from ₹8.9 crore in Q1 FY26 and down 40.8% from ₹18.3 crore in Q4 FY26. Revenue from operations was ₹331 crore, up 11.7% year on year and up 15.2% from the previous quarter.

What was Shalby's revenue in FY26?

Revenue from operations was ₹1,141 crore in FY26 (April 2025–March 2026), up 5.0% from ₹1,087 crore in FY25. It was ₹934 crore in FY24 and ₹805 crore in FY23: up 41.8% over three years, 12.3% a year on average.

What will Shalby's Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit was ₹8.4 crore and revenue from operations ₹285 crore. The latest quarter, Q1 FY27, had a net profit of ₹10.8 crore and revenue of ₹331 crore.

How has Shalby's profit changed over the last four quarters?

Net profit by quarter: ₹8.4 crore in Q2 FY26, ₹1.8 crore in Q3 FY26, ₹18.3 crore in Q4 FY26 and ₹10.8 crore in Q1 FY27. That is ₹39.3 crore over the four quarters. Revenue from operations: ₹285 crore, ₹272 crore, ₹287 crore and ₹331 crore.

What was Shalby's net profit in FY26?

Consolidated net profit was ₹37.4 crore in FY26 (April 2025–March 2026), up 500.9% from ₹6.2 crore in FY25. It was ₹83.5 crore in FY24 and ₹67.7 crore in FY23: down 44.8% over three years, an average fall of 18.0% a year.

Where do these Shalby figures come from?

From Shalby's own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.